UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 24, 2019

MedCann Industries, Inc.

(Exact Name of Registrant as Specified in Its Charter)

10524 Independence Ave.
Chatsworth, CA 91311

(Address of Principal Executive Offices) (Zip Code)

818-357-3185

(Registrant’s Telephone Number, Including Area Code)

North Springs Resources Corp.

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

Under the terms of the Agreement, the company acquired 88% of all the products. The company has agreed to pay the purchase price of $500,000 over a period of 1.5 years. The Agreement is attached hereto as Exhibit 1.01 and incorporated herein by reference.

Item 1.02 Termination of a Material Definitive Agreement.

On June 24, 2019 the company stock issued to Mr. Pulver for back salaries; Mr. Pulver has agreed and return 200,000,000 of his shares back to treasury.

Item 2.02 Results of Operations and Financial Condition.

On Jan 25, 2020, North Springs Resources Corp changed its name to Medcann Industries, Inc.., (the “Company”) issued a press release announcing company names change and structure bringing the company current with all SEC, OTC and FINRA Requirements and are filing the Disclosure Statement and financials for the last Quarter; NSRS is negotiating with private companies in the Cannabis industry looking for beverage, cosmetics, vitamin, and medicinal companies to merge and or joint venture with positive companies. Company also posted on OTC Markets financial and disclosure with the results for the last 2018 quarters and full year ended August 31, 2019. Since then we have not supported OTC Markets and do not file with them. Copy of the release can be found on our website…Exhibit: A (www.medcannindustries.com)

Also on June 10, 2021 John Vivian was elected Pres / CEO / Dir.

The information in Item 2.02 of this Current Report on Form 8-K, including Exhibit (A) attached hereto, shall not be deemed “filed” for purposes of Section 18 of the United States Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the United States Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 3.03 Material Modification to Rights of Security Holders.

As of Nov 2019 200,000,000 have been return to Treasury.

7.01 Regulation FD Disclosure.

The response to Item 2.02 of this Current Report on Form 8-K is incorporated herein by reference.

Item 8.01 Other Events.

The company is entering into several stock purchase Agreements.

Item 9.01 Financial Statements and Exhibits

(b) Exhibits

Attached hereto as Exhibits: (as posted on OTC Markets)

Exhibit

* Incorporated by reference

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.